Nutrient-competency-based CAR-T gene therapy for AML treatment
Innovative CAR-T gene therapy targeting CD44v6 and overexpressing GLUT1 to treat Acute Myeloid Leukemia (AML) by outcompeting leukemia cells for glucose and enhancing anti-leukemia efficacy. Validated in humanized AML mo...